259 related articles for article (PubMed ID: 21901237)
1. Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.
Li D; Xiao J; Paessler M; Zheng XL
Thromb Haemost; 2011 Nov; 106(5):947-58. PubMed ID: 21901237
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
Thomas MR; de Groot R; Scully MA; Crawley JT
EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
[TBL] [Abstract][Full Text] [Related]
3. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.
Zheng XL; Wu HM; Shang D; Falls E; Skipwith CG; Cataland SR; Bennett CL; Kwaan HC
Haematologica; 2010 Sep; 95(9):1555-62. PubMed ID: 20378566
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Jian C; Xiao J; Gong L; Skipwith CG; Jin SY; Kwaan HC; Zheng XL
Blood; 2012 Apr; 119(16):3836-43. PubMed ID: 22289888
[TBL] [Abstract][Full Text] [Related]
5. Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.
Luken BM; Kaijen PH; Turenhout EA; Kremer Hovinga JA; van Mourik JA; Fijnheer R; Voorberg J
J Thromb Haemost; 2006 Nov; 4(11):2355-64. PubMed ID: 16898953
[TBL] [Abstract][Full Text] [Related]
6. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
Starke R; Machin S; Scully M; Purdy G; Mackie I
Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
9. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
[TBL] [Abstract][Full Text] [Related]
10. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
11. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
Matsumoto M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
[TBL] [Abstract][Full Text] [Related]
12. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
[TBL] [Abstract][Full Text] [Related]
13. Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.
Lotta LA; Valsecchi C; Pontiggia S; Mancini I; Cannavò A; Artoni A; Mikovic D; Meloni G; Peyvandi F
J Thromb Haemost; 2014; 12(3):329-36. PubMed ID: 24354764
[TBL] [Abstract][Full Text] [Related]
14. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.
Luken BM; Turenhout EA; Hulstein JJ; Van Mourik JA; Fijnheer R; Voorberg J
Thromb Haemost; 2005 Feb; 93(2):267-74. PubMed ID: 15711742
[TBL] [Abstract][Full Text] [Related]
15. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Lämmle B
Hematology Am Soc Hematol Educ Program; 2012; 2012():610-6. PubMed ID: 23233642
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura.
Coppo P; Wolf M; Veyradier A; Bussel A; Malot S; Millot GA; Daubin C; Bordessoule D; Pène F; Mira JP; Heshmati F; Maury E; Guidet B; Boulanger E; Galicier L; Parquet N; Vernant JP; Rondeau E; Azoulay E; Schlemmer B;
Br J Haematol; 2006 Jan; 132(1):66-74. PubMed ID: 16371021
[TBL] [Abstract][Full Text] [Related]
18. Acquired TTP: ADAMTS13 meets the immune system.
Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
[TBL] [Abstract][Full Text] [Related]
19. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse.
Jin M; Casper TC; Cataland SR; Kennedy MS; Lin S; Li YJ; Wu HM
Br J Haematol; 2008 May; 141(5):651-8. PubMed ID: 18397340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
